LMY-920
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LMY-920, covering 2024-10-18 to 2025-11-10. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1 Study of BAFF CAR-T Cells (LMY-920) for Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia / Small Lymphocytic Lymphoma [Phase 1]